Drug Shortage Report for NAPROSYN
| Report ID | 189849 |
| Drug Identification Number | 02162415 |
| Brand name | NAPROSYN |
| Common or Proper name | Naproxen enteric-coated Tablets |
| Company Name | ATNAHS PHARMA UK LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NAPROXEN |
| Strength(s) | 375MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL ORAL |
| Packaging size | 100s |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2023-04-19 |
| Estimated end date | Unknown |
| Actual end date | 2023-05-25 |
| Shortage status | Resolved |
| Updated date | 2023-05-26 |
| Company comments | Product released |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-05-26 | English | Compare |
| v5 | 2023-05-25 | French | Compare |
| v4 | 2023-05-25 | English | Compare |
| v3 | 2023-04-20 | English | Compare |
| v2 | 2023-04-19 | French | Compare |
| v1 | 2023-04-19 | English | Compare |
Showing 1 to 6 of 6